ASP Isotopes Inc

NASDAQ:ASPIUnited States

NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

ASP Isotopes Inc. is a pre-commercial stage advanced materials company. The Company has a license to use technology, the Aerodynamic Separation Process (ASP technology), originally developed and licensed to it by Klydon Proprietary Ltd (Klydon), for the production, distribution, marketing and sale of all isotopes. Its initial focus is on the production and commercialization of enriched Carbon-14 (C-14), Molybdenum-100 (Mo-100) and Silicon-28 (Si-28). It also intends to develop the ASP technology to produce enriched Uranium-235 (U-235). It operates principally through subsidiaries: ASP Isotopes Guernsey Limited, which is focused on the development and commercialization of high value, low volume isotopes for highly specialized end markets; Enriched Energy LLC, which is focused on the development and commercialization of uranium for the nuclear energy market, and ASP Isotopes UK Ltd, which is the licensee of the ASP technology under the license agreement with Klydon.

Contact Information

Headquarters

433 Plaza Real, Suite 275BOCA RATON, FL, United States 33432

Phone

561-709-3034

Fax

302-636-5454

Executives

Chairman of the Board, Chief Executive Officer

Paul Mann

Interim Chief Financial Officer

Robert Ainscow

Chief Technology Officer, Director

Hendrik Strydom

Director

Sergey Vasnetsov

Independent Director

Joshua Donfeld